![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Theracryf Plc | LSE:TCF | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.775 | 0.75 | 0.80 | 0.775 | 0.775 | 0.775 | 197,320 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 396k | -3.14M | -0.0073 | -1.10 | 3.31M |
TIDMTCF
RNS Number : 8249V
AIM
08 November 2017
NOTICE
08/11/2017 7:00am
NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM
TERRA CATALYST FUND
At the request of the company trading on AIM for the under-mentioned securities has been cancelled from 08/11/2017 7:00am.
ORDINARY SHARES OF 1P EACH, FULLY PAID (DI) (BQSBPL2) (KYG8761F1431)
If you have any queries or require further information, please contact the company's nominated adviser on +44 (0) 207 131 4000.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AMOFMMGMDNRGNZM
(END) Dow Jones Newswires
November 08, 2017 02:00 ET (07:00 GMT)
1 Year Theracryf Chart |
1 Month Theracryf Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions